Surmodics, Inc. (SRDX)
NASDAQ: SRDX · Real-Time Price · USD
36.00
+0.10 (0.28%)
At close: Aug 1, 2025, 4:00 PM
36.03
+0.03 (0.08%)
After-hours: Aug 1, 2025, 4:10 PM EDT

United States Steel Revenue

Surmodics had revenue of $28.09M in the quarter ending March 31, 2025, a decrease of -12.12%. This brings the company's revenue in the last twelve months to $121.58M, down -14.96% year-over-year. In the fiscal year ending September 30, 2024, Surmodics had annual revenue of $126.08M, down -4.91%.

Revenue (ttm)
$121.58M
Revenue Growth
-14.96%
P/S Ratio
4.21
Revenue / Employee
$312,532
Employees
389
Market Cap
515.20M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 2024126.08M-6.51M-4.91%
Sep 30, 2023132.58M32.63M32.65%
Sep 30, 202299.95M-5.19M-4.93%
Sep 30, 2021105.14M10.27M10.83%
Sep 30, 202094.86M-5.21M-5.21%
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sep 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company49.00B
Novo Nordisk43.92B
Revenue Rankings